CTSO - Cytosorbents Crp
Cytosorbents Crp Logo

CTSO - Cytosorbents Crp

https://www.cytosorbents.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

Cytosorbents Corporation, a critical care focused immunotherapy company, is dedicated to the research, development and commercialization of medical devices with its blood purification technology platform incorporating proprietary adsorbent and porous polymer technology. The company is headquartered in Monmouth Junction, New Jersey.

52W High
$1.61
52W Low
$0.71
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
1.29
Valuation
Attractive
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
7.73
EV/EBITDA (<8 favorable)
-1.92
EV/Revenue (<3 favorable)
2.15
P/S (TTM) (<3 favorable)
1.68
P/B (<3 favorable)
5.23
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
15.46%
Institutions (25–75% balanced)
26.67%
Shares Outstanding
62,762,000
Float
54,982,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
36,107,500
Gross Profit (TTM)
24,771,000
EPS (TTM)
-0.18
Profit Margin (>10% good)
-0.27%
Operating Margin (TTM) (higher better)
-0.38%
ROE (TTM) (>15% strong)
-0.70%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
0.09
Momentum
Bearish momentum
Value
-0.0128
Previous
-0.0108
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025